Navigation Links
Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation
Date:4/29/2010

ory to OTC drugs," said Hans Graffner, Chief Medical Officer at Albireo. "The Albireo team looks forward to advancing the development of A3309, a first-in-class compound with a novel mode of action, and to create a new tool in the therapeutic armamentarium for these patients with limited treatment options."

A3309 is currently being evaluated in a large Phase IIb study in chronic constipation enrolling approximately 180 patients in the US and further investigation of A3309's enhancement of large bowel transit is being conducted at the Mayo Clinic. Also, given the mode of action, A3309 may be beneficial in patients with dyslipidemia and a study to evaluate A3309 in patients with high cholesterol levels is conducted in Sweden. Results of these clinical studies will be available late this year and plans are to move forward into Phase III in chronic constipation during 2011.

About the Results Presented at DDW

In the randomized, double-blind, placebo-controlled, prospective dose-escalating study, 30 patients were administered placebo or A3309 in a dose range of 0.1 mg - 10 mg for 14 days. In addition to evaluating safety and tolerability, bowel habits and gastrointestinal symptoms from patient diaries and radiographic assessments of transit were used to assess the efficacy of A3309.

There were no serious adverse events reported and no patient discontinued the trial. Adverse events were evenly distributed across the different dose levels and no difference was observed compared to placebo.

The mode of action - inhibition of bile acid re-absorption in the small bowel - was clearly demonstrated by biomarker analysis and colonic transit was improved in the higher dose groups as was the number of bowel movements. In addition, stool c
'/>"/>

SOURCE Albireo AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
2. Synergetics USA Announces Conference Call
3. Roche Announces Joint Initiative to Train Healthcare Workers in Africas Fight Against Cancer
4. Perrigo Company Announces Quarterly Dividend
5. Onyx Pharmaceuticals Announces First Quarter 2010 Financial Results Teleconference and Webcast
6. ATS Medical Announces Participation in the 90th Annual Meeting of the American Association for Thoracic Surgeons
7. Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan
8. B. Braun Renal Therapies Division Announces Availability of Adimea
9. RedVision Announces Integrated Client Workflow Platform: TitleVision2 The Power of Two
10. Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast
11. Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... TORONTO , May 22 2015 /CNW/ - The Taskforce ... are very appreciative of all the hard work that the ... the past six months. This program recognizes the needs of ... receive at least $75,000 a year, tax free, with annual ... will be eligible for annual payments of $100,000 based on ...
(Date:5/22/2015)... mayo de 2015 Dipexium Pharmaceuticals, ... farmacéutica de fase tardía centrada en el ... 0.8%), y colaboradores de investigación clínica, han ... el diseño innovador de los ensayos pivotales ... evalúan Locilex®, su nuevo péptido de antibiótico ...
(Date:5/22/2015)... 2015  Effective staffing of key marketing services ... success. Research and consulting leader ... pharmaceutical and biotech marketing managers with metrics detailing ... are being channeled into marketing operations of global ... utilize this report to benchmark their own resource ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2
... Sciences International, Inc. (Nasdaq: BDSI ) announced ... Officer of BDSI, will present at the Jeffries Global ...  The presentation is scheduled for Thursday, June 9 at ... http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Dr. Sirgo will focus on ...
... bioTheranostics, Inc., a bioMerieux company that develops innovative ... today findings from clinical studies utilizing the company,s ... the studies were presented this week at the ... Meeting in Chicago. On June 6, ...
Cached Medicine Technology:BioDelivery Sciences to Present at the Jeffries Global Healthcare Conference 2BioDelivery Sciences to Present at the Jeffries Global Healthcare Conference 3Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting 2Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting 3
(Date:5/22/2015)... Francisco, CA (PRWEB) May 22, 2015 ... hosting two exciting events in June. They will hold ... Professional Doctorate and a two-day class on Classical Chinese ... p.m. June 3, Dr. Steve Given, the Dean of ... will discuss the new First Professional Doctorate program. ACTCM ...
(Date:5/22/2015)... York, New York (PRWEB) May 22, 2015 ... http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who ... due to its use continue to move forward ... Louisiana. According to a Pretrial Order dated May ... the preservation of documents and electronically stored information. ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Combination ... treatment option for chronic obstructive pulmonary disorder (COPD) ... plc and AstraZeneca plc as well as Germany’s ... share and position. But will market payers, clinicians ... already well-entrenched products to completely new ones? , ...
(Date:5/22/2015)... Family, friends, students, colleagues, mentors and ... Dr. LaSalle D. Leffall, on Monday, May 18, with ... Grand Rounds in the hospital’s Tower Auditorium. Leffall’s younger ... auditorium, trying to keep the secret. “I’d like to ... me, he’ll know something is up,” she said. , ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Memorial Day weekend ... Amica Insurance is offering some tips to help promote ... Council, there will be 383 traffic fatalities this Memorial Day ... the National Highway Traffic Safety Association: , ... the vehicle is wearing a seatbelt, whether they’re driving or ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming June Events 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2
... With infections typically causing only mild illness, experts point to ... (HealthDay News) -- With all the warnings and preparations, dire ... H1N1 swine flu prove more disruptive than the actual outbreak? ... than a few infectious-disease experts as the fall and winter ...
... SEATTLE, Sept. 22 Milliman, Inc., one of the premier worldwide ... new office in San Juan, Puerto Rico. The consultancy, in concert ... expanding the range and depth of Milliman health-related service offerings. , ... years of experience are ideally suited to meeting client needs in ...
... , RADNOR, Pa., Sept. 22 Eric Hipple, ... Feeling Blue Suicide Prevention Council,s Swing into Life! Golf Tournament, Wednesday, ... former National Football League (NFL) quarterback whose ten year career was ... a divisional championship, and the most valuable NFL player award for ...
... , , , ... Bulletin Board: AEMD) today announced that it has initiated ... to support large-scale production of the active affinity agents ... allow the Hemopurifer(R) to selectively capture a broad-spectrum of ...
... PITTSBURGH, Sept. 22 Cohera Medical, Inc. announced ... 13485:2003 International Standard for the Design, Development, and Manufacture ... Cohera Medical to proceed with the CE Mark registration ... surgical adhesive, upon completion of development for its first ...
... PITTSBURGH, Sept. 22 Precision Therapeutics today announced that its ... Business Magazine 2009 Pacesetters Award. This award recognizes business ... setting the pace for the region. The award honors ... in the community-at-large as well as within their own organizations, ...
Cached Medicine News:Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 2Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 3Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 4Health News:Milliman Announces the Opening of a New Office in San Juan, Puerto Rico 2Health News:Former NFL Quarterback to Speak at Local Nonprofit Fundraising Event 2Health News:Aethlon Medical Initiates Relationship to Establish Large Scale Production of Hemopurifier(R) Affinity Agents 2Health News:Aethlon Medical Initiates Relationship to Establish Large Scale Production of Hemopurifier(R) Affinity Agents 3Health News:Cohera Medical Receives ISO 13485 Certification: Company Meets International Standards for Design, Development and Manufacturing of Medical Devices 2Health News:Precision Therapeutics President and CEO Sean McDonald Recipient of 2009 Pacesetters Award 2
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Medicine Products: